Discover the complete record of transactions filed by 조병기, Chief Executive Officer. Director active across 2 companies, notably 바이오노트. Aggregated, 17,943 reports have been recorded. History available since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Cho Byeong-ki is the CEO of BioNote. He oversees the company's operations and is responsible for implementing the business strategy, aiming to promote innovation and growth in the biotechnology sector.